Sheller Joins Phila. in Suit Against Opioid Manufacturers
Sheller PC is one of five private law firms assisting the city of Philadelphia’s Law Department in its suit against pharmaceutical companies attempting to hold them accountable for the current opioid crisis. Five pharmaceutical companies are named in the suit: Allergan, Janssen (a subsidiary of Johnson & Johnson and manufacturer of Risperdal), Endo, Cephalon, and […]
Superior Court Allows Punitive Damages in Risperdal Mass Torts
In a significant ruling by the Pennsylvania Superior Court, Janssen, a subsidiary of Johnson & Johnson (J&J), will now face punitive damages in Risperdal mass tort suits. A previous Philadelphia trial court ruling prohibited punitive damages. Boys and young men who developed gynecomastia, female-like breasts, from taking the antipsychotic drug and whose cases had already […]
Plaintiff wins Bellwether Xarelto Case in Philadelphia Court
A Philadelphia jury awarded Lynn Hartman $27.8 million after finding drug manufacturers Johnson & Johnson and Bayer failed to warn about the dangers of their blood thinning drug Xarelto. The verdict includes $26 million in punitive damage, which juries award to plaintiffs when they believe the defendant acted egregiously. This bellwether case tried in Pennsylvania […]
HHS Pick, Former Eli Lilly Exec, Grilled over Zyprexa Scandal
Lone Risperdal Defense Verdict for J&J Overturned
Shellers honored as National Liberty Museum’s “2017 Heroes of Liberty”
The National Liberty Museum honored Stephen and Sandra Sheller as “2017 Heroes of Liberty” at the 18th Annual Glass Auction & Gala held on October 7, 2017 at the Sheraton Philadelphia Downtown Hotel. The Shellers were recognized for their support of the Museum and the community through their nonprofit organizations The Sheller Family Foundation and […]
SCOTUS Ruling Increases Risperdal Suits in PA
Risperdal litigation in Philadelphia courts have increased significantly this year and the trend is likely to continue. Mass torts against Janssen, a Johnson & Johnson subsidiary, over it’s antipsychotic drug Risperdal has nearly tripled in Pennsylvania. Plaintiff attorneys say the biggest cause for the recent influx is the expiration of a tolling agreement between Janssen […]
Checkbook Science
In 1984 a federal jury in San Francisco found Dow Corning’s breast implants were “defectively designed and manufactured.” Maria Stern was awarded $1.7 M after internal corporate memos and studies show that Dow had failed to warn the public of the health risks associated with breast implants. Evidence from the case was sealed by the […]
The Chamber: ‘One More Bullet in J&J’s Gun’
In ‘For Plaintiffs Bar, Taking on J&J Means Battling a Shadow Foe,’ Law.com’s Amanda Bronstad reports on the “intimate relationship” between Johnson & Johnson (J&J) and the U.S. Chamber of Commerce (the Chamber). The U.S. Chamber of Commerce is not a government entity, but a powerful group of lobbyists, the largest in the nation. Plaintiff’s lawyers point out […]
Breast Implant Safety Controversy Fueled by Junk Science
A new type of lymphoma called breast implant-associated anapestic large-cell lymphoma has medical authorities finally agreeing that the prosthetics can cause disease. The first recognized case was in 1997, however a warning from the U.S. Food and Drug Administration was not released until 2011. Six years later, experts say awareness among doctors is low and most […]
